Trial intelligence / Profile preview

Pioglitazone for Endothelial Function in SLE

NCT01322308Phase 4Completed

Start
Mar 2007
Primary completion
Jan 2012
Modality
Small Molecules
01

Overview

A Phase 4 trial of pioglitazone in systemic lupus erythematosus (SLE). Started Mar 2007; status: completed.

02

Drugs

pioglitazone
03

Conditions

systemic lupus erythematosus (SLE)

Beyond the preview

Go deeper on NCT01322308.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01322308.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call